Clinical Trials Browser

Phase 1 × Has results × alvocidib × Clear all

NCT03298984 2023-11-15

Ph I Study of Alvocidib and Cytarabine/Daunorubicin (7+3) in Patients With Newly Diagnosed Acute Myeloid Leukemia (AML).

Phase 1 Completed

32 enrolled 15 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute